These findings reinforce our observation that impairing RNA processing and metabolism in ribosome biogenesis, through downregulation of CEBPZ, NOC2L or NOC3L, alters key cellular pathways, potentially contributing to tumor progression in a cell-type-specific manner, particularly in kidney-derived cancers, such as KICH. Here, NOC2L is linked to cancer.